Body Vision Medical
Body Vision Medical is a privately held medical device company that develops the LungVision AI-powered intraoperative imaging platform, transforming conventional 2D C-arm fluoroscopy into real-time 3D imaging for image-guided lung cancer biopsy during bronchoscopy, sold to hospitals and interventional pulmonology programs globally.
- Company typePrivate
- Founded2014
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Body Vision Medical does
Body Vision Medical is a privately held medical device company founded in 2014, headquartered in Waltham, Massachusetts, that develops and commercializes the LungVision System, an AI-powered intraoperative imaging platform for lung cancer diagnostics and image-guided biopsy during bronchoscopy. The company's core technology—proprietary AI Tomo and C-Arm Based Tomography (CABT)—reconstructs real-time 3D volumetric images from any conventional 2D fluoroscopic C-arm, correcting for CT-to-body divergence and providing visual tool-in-lesion confirmation before biopsy. The firm serves interventional pulmonologists, thoracic surgeons, and the hospitals and medical centers where they practice, and reports diagnostic yields approaching 90–95% with LungVision compared to historical 55–75% baselines, at approximately one-fifth the radiation dose of dedicated 3D C-arm systems.
The product portfolio centers on the LungVision System, comprising the AI Tomo imaging engine, augmented fluoroscopy, virtual bronchoscopy, 3D multi-planar review, and disposable procedural kits containing pre-curved catheters with radiopaque markers. The platform integrates with C-arms from GE HealthCare, Siemens, Ziehm Imaging, Fujifilm, and Xoran, and is compatible with robotic bronchoscopy platforms including the Auris Monarch (Ethicon/J&J) and Ion by Intuitive, positioning LungVision as both a standalone navigation system and an adjunct to robotic platforms. Regulatory footprint includes EU-MDR certification and 2025 approvals in Singapore (HSA), Australia (TGA), India (CDSCO), and Brazil (ANVISA).
The business model combines one-time capital sales of the LungVision console to hospitals with recurring revenue from single-use procedural kits and service and training contracts. The firm employs an enterprise field-sales motion domestically, complemented by a global distributor network (Mediflex, Healthcare Links, DK Healthcare, AMCO, HugeMed, Business Asia Consultants, Bio Scan S.A.) and group purchasing organization contracts with Vizient and Premier. End-markets span the United States, Europe, APAC, Latin America, the Middle East, and Africa, with named customers including Cleveland Clinic, John Muir Health, University of Chicago, WVU Camden Clark, North Memorial Health, Luisenhospital Aachen, and Carmel Medical Center. Leadership includes CEO Matt Baker (appointed 2023), CFO Momi Karako (formerly Partner at Pontifax Venture Capital), and CMO Dr. Yael Vin (interventional radiologist).
Body Vision Medical firmographics
Firmographics- Name
- Body Vision Medical
- Legal name
- Body Vision Medical Inc.
- Website
- http://www.bodyvisionmedical.com/
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Body Vision Medical is a privately held medical device company that develops the LungVision AI-powered intraoperative imaging platform, transforming conventional 2D C-arm fluoroscopy into real-time 3D imaging for image-guided lung cancer biopsy during bronchoscopy, sold to hospitals and interventional pulmonology programs globally.
- Ownership category
- akta.pro rank
Body Vision Medical industry classification
Industry- Product category
- Interventional Imaging Systems
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)
- akta.pro secondary industry
- Medical Imaging AI (HDAAAEAH)
Keywords
Where Body Vision Medical is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Body Vision Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Revenue model
- LungVision System Sales: Body Vision Medical sells the LungVision AI-powered intraoperative imaging system to hospitals and medical institutions. The system includes hardware (workstation/console) and software components. The company also offers procedural kits as disposable supplies used during procedures.
- Procedural Kits (Disposables): Single-use procedural kits containing specialized catheters and accessories used during LungVision-guided procedures. Optional low-cost-per-case kits compared to other navigation technologies.
- Service and Training: The company provides system service, training, and support services to customers, including training scheduling and ongoing technical support.
Go-to-market motion3 records
Distribution channels10 records
Marketing channels8 records
Body Vision Medical product offering
Product offeringCore offering
Body Vision Medical develops and sells the LungVision System, an AI-powered intraoperative imaging platform that transforms any conventional 2D C-arm fluoroscope into a real-time 3D CT imaging system for lung cancer diagnostics during bronchoscopy. The proprietary AI Tomo technology corrects for CT-to-body divergence and provides visual tool-in-lesion confirmation, with disposable procedural kits sold as consumables used during procedures. The company also provides service, training, and technical support to hospital customers worldwide.
Product overview
Body Vision Medical offers the LungVision System, an AI-powered intraoperative imaging platform designed for lung cancer diagnostics. The core platform consists of proprietary AI Tomo technology that transforms any conventional 2D C-arm into an advanced 3D imaging system. Key components include C-Arm Based Tomography (CABT) for real-time intraoperative CT imaging, Augmented Fluoroscopy for live navigation guidance, Virtual Bronchoscopy for pathway planning, and 3D View for interactive visualization. The system is used with disposable Procedural Kits containing specialized catheters with radiopaque markers. LungVision integrates with multiple C-arm manufacturers (Siemens, GE HealthCare, Ziehm Imaging, Fujifilm, Xoran) and robotic bronchoscopy platforms (Auris Monarch, Ion by Intuitive) to provide real-time imaging that corrects for CT-to-body divergence during lung nodule biopsy procedures.
Differentiator
Problem solved
Functional benefit
Products and services
- LungVision System AI-powered intraoperative imaging platform that transforms conventional 2D C-arm fluoroscopy into real-time 3D CT imaging for lung cancer diagnostics. Enables navigation, tool-in-lesion confirmation, and image-guided biopsy during bronchoscopy procedures. Includes the AI Tomo workstation/console with proprietary AI Tomo software and integrates with existing C-arm inventory. Sold to hospitals, academic medical centers, and community hospitals.
- LungVision Procedural Kit Disposable procedural kit including pre-curved extended working channel catheter with radiopaque markers for enhanced visualization under fluoroscopy. Used for navigation and tool delivery to peripheral lung lesions during LungVision-guided procedures. Sold as single-use consumables to hospitals performing LungVision procedures.
- LungVision System Training and Service System service, training, and technical support services provided to customers, including training scheduling and ongoing technical support for LungVision System users at hospitals and medical centers.
Quantifiable outcome
- Diagnostic yield improvement from 55-75% to 90%+
- +7 more outcomes
Companies that use Body Vision Medical
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles2 records
Body Vision Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration9 records
AI capability5 records
Feature6 records
Body Vision Medical partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core, regional and strategic.
- VizientcoreInnovative Technology Contract enabling Vizient member hospitals to access LungVision system through group purchasing agreement.
- HugeMedregionalDistribution partnership agreement for LungVision system sales.
- AMCO IncorporatedregionalExclusive distribution agreement for LungVision system in defined territory.
- FujifilmcoreSuccessful validation of LungVision system with Fujifilm's range of surgical C-arms, expanding compatibility with additional C-arm manufacturers.
- DK Healthcare Co., Ltd.regionalDistribution agreement signed for LungVision system distribution, supporting market entry in the Asia-Pacific region.
- Premier, Inc.coreGroup purchasing agreement awarded for LungVision system, enabling access through Premier's hospital network.
- Bio Scan S.A.regionalDistribution agreement for Mexico expanding distribution footprint in Central and South America.
- Ziehm ImagingcoreSuccessful validation of LungVision system with Ziehm Imaging's mobile C-arms, enabling compatibility with Ziehm equipment for intraoperative imaging.
- MediflexcoreGlobal distribution agreement for LungVision system sales. Mediflex serves as a key distribution partner enabling broader market access for the LungVision platform internationally.
- Healthcare LinkscoreNational accounts partnership for hospital system coverage and distribution in the United States.
- GE HealthCarecoreAnnounced compatibility of LungVision intraoperative imaging with 2D feature of GE HealthCare's OEC 9800, 9900, Elite, and OEC 3D C-arms, enabling integration with GE's surgical imaging equipment.
- Xoran TechnologiesstrategicSuccessful validation of LungVision intraoperative imaging with TRON mobile fluoroscopy-CT system, expanding imaging capabilities.
- Business Asia Consultants, Inc.regionalPartnership accelerating international expansion in the Asia-Pacific region through local market expertise and connections.
Scale indicators11 records
Recent moves7 records
Expansion highlights5 records
Body Vision Medical competitors and assessment
Company assessmentDirect peers
- Medtronic: Holds the legacy superDimension electromagnetic navigation bronchoscopy (ENB) franchise — Body Vision's founders previously commercialized ENB at superDimension — and remains a competing navigation modality in lung biopsy.
- Intuitive Surgical: Developer of the Ion robotic bronchoscopy platform, which directly competes with Body Vision for navigational bronchoscopy procedures and increasingly bundles its own imaging capabilities — the single most important competitive threat to LungVision.
- Noah Medical: Emerging robotic bronchoscopy competitor (Galaxy System) targeting the same interventional pulmonology customer base and lung-nodule biopsy use case as Body Vision, with growing U.S. adoption.
- Johnson & Johnson (Ethicon / Auris Health): Markets the Monarch robotic bronchoscopy platform (acquired via Auris Health), a head-to-head competitor to both Body Vision and Intuitive's Ion in lung-nodule biopsy, with significant scale advantages in hospital sales.
Others
- Fujifilm Healthcare: Validated partner for surgical C-arm compatibility with LungVision, and a broader player in endoscopy and surgical imaging whose installed base Body Vision addresses.
- GE HealthCare: Manufacturer of the OEC C-arm family (9800, 9900, Elite, OEC 3D) validated to work with LungVision — both a critical technology partner and a potential competitive threat if it integrates similar AI 3D-reconstruction capabilities into its own surgical imaging roadmap.
- Ziehm Imaging: Mobile C-arm manufacturer whose systems are validated with LungVision — a complementary partner but also a potential competitor if it pursues AI-based 3D reconstruction natively.
Broad incumbents
- Siemens Healthineers: Sells the Cios Spin 3D C-arm and Artis Zee 2D C-arm systems validated for LungVision; a broad incumbent in surgical imaging whose installed base Body Vision monetizes but which could compete with dedicated 3D imaging.
- Philips: Major surgical and interventional imaging incumbent (Azurion, Philips Image-Guided Therapy) overlapping in the procedural imaging space where Body Vision competes for hospital capital budgets.
Emerging players
- Xoran Technologies: Developer of the TRON mobile fluoroscopy-CT system, validated as an integrated partner with LungVision; competes in point-of-care CT imaging for interventional pulmonology and similar minimally invasive procedures.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Body Vision Medical social profiles
Digital presenceBody Vision Medical compliance and trust
Trust signalCompliance5 records
Body Vision Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Body Vision Medical leadership team
Management profileNumber of profiles
Profiles9 records
Body Vision Medical funding detail
Funding detailFunding overview
Funding rounds5 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Body Vision Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Body Vision Medical
What does Body Vision Medical do?
Body Vision Medical develops and sells the LungVision System, an AI-powered intraoperative imaging platform that transforms any conventional 2D C-arm fluoroscope into a real-time 3D CT imaging system for lung cancer diagnostics during bronchoscopy. The proprietary AI Tomo technology corrects for CT-to-body divergence and provides visual tool-in-lesion confirmation, with disposable procedural kits sold as consumables used during procedures. The company also provides service, training, and technical support to hospital customers worldwide.
Is Body Vision Medical a public or private company?
Body Vision Medical is a private company. It is classified as venture growth investor backed and is currently operating.
When was Body Vision Medical founded?
Body Vision Medical was founded in 2014. It employs 11 to 50 people.
Where is Body Vision Medical based?
Body Vision Medical is headquartered in New York, United States, in the North America region.
How does Body Vision Medical make money?
Three revenue lines are on record. LungVision System Sales are the primary driver. The others are procedural Kits (Disposables) and service and Training.
Who are Body Vision Medical's main competitors?
Direct peers on record are Medtronic, Intuitive Surgical, Noah Medical and Johnson & Johnson (Ethicon / Auris Health). Others are Fujifilm Healthcare, GE HealthCare and Ziehm Imaging. Broad incumbents are Siemens Healthineers and Philips. Xoran Technologies is listed as an emerging player.
Does Body Vision Medical have an API?
No public API is recorded for Body Vision Medical.
What industry is Body Vision Medical in?
Body Vision Medical's product category is Interventional Imaging Systems. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 339112 and its SIC code is 3841.